{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T11:10:04Z","timestamp":1792408204011,"version":"4.4.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T00:00:00Z","timestamp":1726012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T00:00:00Z","timestamp":1726012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Agents Cancer"],"DOI":"10.1186\/s13027-024-00604-4","type":"journal-article","created":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T21:02:02Z","timestamp":1726088522000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["High-grade B-cell lymphoma with 11q aberration in the HIV setting: a clinicopathological study of 10 cases and literature review"],"prefix":"10.1186","volume":"19","author":[{"given":"Jing","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxue","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fudong","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhujun","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjia","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mulan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,11]]},"reference":[{"issue":"20","key":"604_CR1","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1182\/blood-2016-03-657379","volume":"127","author":"M Cazzola","year":"2016","unstructured":"Cazzola M. Introduction to a review series: the 2016 revision of the WHO classification of tumors of hematopoietic and lymphoid tissues. Blood. 2016;127(20):2361\u20134.","journal-title":"Blood"},{"issue":"7","key":"604_CR2","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: lymphoid neoplasms. Leukemia. 2022;36(7):1720\u201348.","journal-title":"Leukemia"},{"issue":"11","key":"604_CR3","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1182\/blood.2022015851","volume":"140","author":"E Campo","year":"2022","unstructured":"Campo E, Jaffe ES, Cook JR, Quintanilla-Martinez L, Swerdlow SH, Anderson KC, et al. The International Consensus classification of mature lymphoid neoplasms: a report from the Clinical Advisory Committee. Blood. 2022;140(11):1229\u201353.","journal-title":"Blood"},{"issue":"16","key":"604_CR4","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38(16):e164.","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"604_CR5","doi-asserted-by":"publisher","first-page":"e275","DOI":"10.3324\/haematol.2015.124305","volume":"100","author":"JF Ferreiro","year":"2015","unstructured":"Ferreiro JF, Morscio J, Dierickx D, Marcelis L, Verhoef G, Vandenberghe P, et al. Post-transplant molecularly defined Burkitt lymphomas are frequently MYC-negative and characterized by the 11q-gain\/loss pattern. Haematologica. 2015;100(7):e275\u2013279.","journal-title":"Haematologica"},{"issue":"4","key":"604_CR6","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/QAD.0000000000000071","volume":"28","author":"PG Rubinstein","year":"2014","unstructured":"Rubinstein PG, Aboulafia DM, Zloza A. Malignancies in HIV\/AIDS: from epidemiology to therapeutic challenges. Aids. 2014;28(4):453\u201365.","journal-title":"Aids"},{"issue":"3","key":"604_CR7","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1158\/1055-9965.EPI-16-0595","volume":"26","author":"X Han","year":"2017","unstructured":"Han X, Jemal A, Hulland E, Simard EP, Nastoupil L, Ward E, et al. HIV Infection and Survival of Lymphoma Patients in the era of highly active antiretroviral therapy. Cancer Epidemiol Biomarkers Prev. 2017;26(3):303\u201311.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"604_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/ajcp\/aqx139","volume":"149","author":"B Grygalewicz","year":"2017","unstructured":"Grygalewicz B, Woroniecka R, Rymkiewicz G, Rygier J, Borkowska K, Kotyl A, et al. The 11q-Gain\/Loss aberration occurs recurrently in MYC-Negative Burkitt-like Lymphoma with 11q aberration, as well as MYC-Positive Burkitt Lymphoma and MYC-Positive high-Grade B-Cell Lymphoma, NOS. Am J Clin Pathol. 2017;149(1):17\u201328.","journal-title":"Am J Clin Pathol"},{"issue":"23","key":"604_CR9","doi-asserted-by":"publisher","first-page":"5220","DOI":"10.1182\/bloodadvances.2021004635","volume":"5","author":"N Gebauer","year":"2021","unstructured":"Gebauer N, Witte HM, Merz H, Oschlies I, Klapper W, Caliebe A, et al. Aggressive B-cell lymphoma cases with 11q aberration patterns indicate a spectrum beyond Burkitt-like lymphoma. Blood Adv. 2021;5(23):5220\u20135.","journal-title":"Blood Adv"},{"issue":"1","key":"604_CR10","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1515\/med-2021-0246","volume":"16","author":"J Wang","year":"2021","unstructured":"Wang J, Ma L, Guo J, Xi Y, Xu E. Burkitt-like lymphoma with 11q aberration in a patient with AIDS and a patient without AIDS: two cases reports and literature review. Open Med (Wars). 2021;16(1):428\u201334.","journal-title":"Open Med (Wars)"},{"issue":"6","key":"604_CR11","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/his.14798","volume":"81","author":"MJ Baptista","year":"2022","unstructured":"Baptista MJ, Tapia G, Mu\u00f1oz-Marmol AM, Muncunill J, Garcia O, Montoto S, et al. Genetic and phenotypic characterisation of HIV-associated aggressive B-cell non-hodgkin lymphomas, which do not occur specifically in this population: diagnostic and prognostic implications. Histopathology. 2022;81(6):826\u201340.","journal-title":"Histopathology"},{"issue":"9","key":"604_CR12","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.3324\/haematol.2018.207928","volume":"104","author":"B Gonzalez-Farre","year":"2019","unstructured":"Gonzalez-Farre B, Ramis-Zaldivar JE, Salmeron-Villalobos J, Balagu\u00e9 O, Celis V, Verdu-Amoros J, et al. Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma. Haematologica. 2019;104(9):1822\u20139.","journal-title":"Haematologica"},{"issue":"6","key":"604_CR13","doi-asserted-by":"publisher","first-page":"593","DOI":"10.3343\/alm.2021.41.6.593","volume":"41","author":"JA Kim","year":"2021","unstructured":"Kim JA, Kim HY, Kim SJ, Kim HJ, Kim SH. A case of Burkitt-Like Lymphoma with 11q aberration with HIV infection in East Asia and Literature Review. Ann Lab Med. 2021;41(6):593\u20137.","journal-title":"Ann Lab Med"},{"issue":"12","key":"604_CR14","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1056\/NEJMcpc1800321","volume":"378","author":"KL Ard","year":"2018","unstructured":"Ard KL, Kelly HR, Gandhi RT, Louissaint A, Jr. Case 9-2018: a 55-Year-old man with HIV infection and a Mass on the right side of the Face. N Engl J Med. 2018;378(12):1143\u201352.","journal-title":"N Engl J Med"},{"issue":"11","key":"604_CR15","doi-asserted-by":"publisher","first-page":"e495","DOI":"10.1016\/S2352-3018(17)30125-X","volume":"4","author":"RU Hern\u00e1ndez-Ram\u00edrez","year":"2017","unstructured":"Hern\u00e1ndez-Ram\u00edrez RU, Shiels MS, Dubrow R, Engels EA. Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study. Lancet HIV. 2017;4(11):e495\u2013504.","journal-title":"Lancet HIV"},{"issue":"7","key":"604_CR16","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1182\/blood.2020005469","volume":"139","author":"A Carbone","year":"2022","unstructured":"Carbone A, Vaccher E, Gloghini A. Hematologic cancers in individuals infected by HIV. Blood. 2022;139(7):995\u20131012.","journal-title":"Blood"},{"issue":"8","key":"604_CR17","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1038\/s41379-020-0506-3","volume":"33","author":"Y Fedoriw","year":"2020","unstructured":"Fedoriw Y, Selitsky S, Montgomery ND, Kendall SM, Richards KL, Du W, et al. Identifying transcriptional profiles and evaluating prognostic biomarkers of HIV-associated diffuse large B-cell lymphoma from Malawi. Mod Pathol. 2020;33(8):1482\u201391.","journal-title":"Mod Pathol"},{"issue":"2","key":"604_CR18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3960\/jslrt.23007","volume":"63","author":"S Yamada","year":"2023","unstructured":"Yamada S, Oka Y, Muramatsu M, Hashimoto Y. High-grade B-cell lymphoma with 11q aberrations: a single-center study. J Clin Exp Hematop. 2023;63(2):121\u201331.","journal-title":"J Clin Exp Hematop"},{"issue":"3","key":"604_CR19","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1097\/PAS.0000000000001613","volume":"45","author":"H Horn","year":"2021","unstructured":"Horn H, Kalmbach S, Wagener R, Staiger AM, H\u00fcttl K, Mottok A, et al. A Diagnostic Approach to the identification of Burkitt-like Lymphoma with 11q aberration in aggressive B-Cell lymphomas. Am J Surg Pathol. 2021;45(3):356\u201364.","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"604_CR20","first-page":"604","volume":"50","author":"YP Zhang","year":"2021","unstructured":"Zhang YP, Zhang L, Zhang DD, Wang GN, Zhao WG, Jian XY, et al. [Clinicopathological and molecular genetic features of Burkitt-like lymphoma with 11q aberration]. Zhonghua Bing Li Xue Za Zhi. 2021;50(6):604\u20138.","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"issue":"4","key":"604_CR21","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1097\/PAS.0000000000002160","volume":"48","author":"T Zhou","year":"2024","unstructured":"Zhou T, Wang HW, Ng SB, Summers T, Xi L, Raffeld M, et al. Tissue Eosinophilia in B-cell lymphoma: an underrecognized phenomenon. Am J Surg Pathol. 2024;48(4):426\u201336.","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"604_CR22","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00428-023-03590-x","volume":"483","author":"L Quintanilla-Martinez","year":"2023","unstructured":"Quintanilla-Martinez L, Laurent C, Soma L, Ng SB, Climent F, Ondrejka SL, et al. Emerging entities: high-grade\/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP\/SH lymphoma workshop. Virchows Arch. 2023;483(3):281\u201398.","journal-title":"Virchows Arch"},{"issue":"7","key":"604_CR23","doi-asserted-by":"publisher","first-page":"100170","DOI":"10.1016\/j.modpat.2023.100170","volume":"36","author":"SN Hurwitz","year":"2023","unstructured":"Hurwitz SN, Lockhart B, \u00d6nder \u00d6, Wu R, Sethi S, Aypar U, et al. Proteogenomic profiling of high-Grade B-Cell Lymphoma with 11q aberrations and Burkitt Lymphoma reveals lymphoid enhancer binding factor 1 as a Novel Biomarker. Mod Pathol. 2023;36(7):100170.","journal-title":"Mod Pathol"},{"issue":"5","key":"604_CR24","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/modpathol.2017.186","volume":"31","author":"G Rymkiewicz","year":"2018","unstructured":"Rymkiewicz G, Grygalewicz B, Chechlinska M, Blachnio K, Bystydzienski Z, Romejko-Jarosinska J, et al. A comprehensive flow-cytometry-based immunophenotypic characterization of Burkitt-like lymphoma with 11q aberration. Mod Pathol. 2018;31(5):732\u201343.","journal-title":"Mod Pathol"},{"issue":"3","key":"604_CR25","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/path.6246","volume":"262","author":"SE Coupland","year":"2024","unstructured":"Coupland SE, Du MQ, Ferry JA, de Jong D, Khoury JD, Leoncini L, et al. The fifth edition of the WHO classification of mature B-cell neoplasms: open questions for research. J Pathol. 2024;262(3):255\u201370.","journal-title":"J Pathol"},{"issue":"8","key":"604_CR26","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1182\/blood-2013-06-507996","volume":"123","author":"I Salaverria","year":"2014","unstructured":"Salaverria I, Martin-Guerrero I, Wagener R, Kreuz M, Kohler CW, Richter J, et al. A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma. Blood. 2014;123(8):1187\u201398.","journal-title":"Blood"},{"issue":"4","key":"604_CR27","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/QAD.0b013e32834f30fa","volume":"26","author":"C Wyen","year":"2012","unstructured":"Wyen C, Jensen B, Hentrich M, Siehl J, Sabranski M, Esser S, et al. Treatment of AIDS-related lymphomas: Rituximab is beneficial even in severely immunosuppressed patients. Aids. 2012;26(4):457\u201364.","journal-title":"Aids"},{"issue":"21","key":"604_CR28","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1200\/JCO.23.00737","volume":"41","author":"K Lurain","year":"2023","unstructured":"Lurain K. Treating Cancer in people with HIV. J Clin Oncol. 2023;41(21):3682\u20138.","journal-title":"J Clin Oncol"},{"issue":"5","key":"604_CR29","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/bjh.16578","volume":"190","author":"RKH Au-Yeung","year":"2020","unstructured":"Au-Yeung RKH, Arias Padilla L, Zimmermann M, Oschlies I, Siebert R, Woessmann W, et al. Experience with provisional WHO-entities large B-cell lymphoma with IRF4-rearrangement and Burkitt-like lymphoma with 11q aberration in paediatric patients of the NHL-BFM group. Br J Haematol. 2020;190(5):753\u201363.","journal-title":"Br J Haematol"}],"container-title":["Infectious Agents and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-024-00604-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13027-024-00604-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-024-00604-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T21:02:16Z","timestamp":1726088536000},"score":1,"resource":{"primary":{"URL":"https:\/\/infectagentscancer.biomedcentral.com\/articles\/10.1186\/s13027-024-00604-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,11]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["604"],"URL":"https:\/\/doi.org\/10.1186\/s13027-024-00604-4","relation":{},"ISSN":["1750-9378"],"issn-type":[{"value":"1750-9378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,11]]},"assertion":[{"value":"8 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Beijing Youan Hospital and performed in accordance with the 1975 Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42"}}